AstraZeneca plans direct listing on NYSE but won’t exit London The Globe and Mail Politics
AstraZeneca plans direct listing on New York Stock Exchange but isn’t quitting London The Guardian Politics
AstraZeneca Plans To ‘Harmonize’ New York and London Listings insights.citeline.com Politics
AstraZeneca plans New York Stock Exchange listing but isn’t quitting London The Guardian Politics
The Cambridge-based firm is set to directly list its ordinary shares on the New York Stock Exchange amid an increased focus on the US. Politics
UK drugmaker says it intends to create a ‘global listing for a global company’ Economics
UK drugmaker to ditch American depositary receipts in favour of more liquid ordinary shares Economics